Published in Ann Diagn Pathol on November 03, 2011
Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood (2002) 6.73
A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape. J Immunol (2002) 3.07
Transient regulatory T-cells: a state attained by all activated human T-cells. Clin Immunol (2006) 2.56
Elucidation of seventeen human peripheral blood B-cell subsets and quantification of the tetanus response using a density-based method for the automated identification of cell populations in multidimensional flow cytometry data. Cytometry B Clin Cytom (2010) 2.38
Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumab. Arch Neurol (2008) 1.88
Immunophenotypic differentiation between neoplastic plasma cells in mature B-cell lymphoma vs plasma cell myeloma. Am J Clin Pathol (2007) 1.82
High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood (2004) 1.62
The oligodendrocyte-specific G protein-coupled receptor GPR17 is a cell-intrinsic timer of myelination. Nat Neurosci (2009) 1.60
Myeloid sarcoma involving the gynecologic tract: a report of 11 cases and review of the literature. Am J Clin Pathol (2006) 1.59
Management of anomalies of the third and fourth branchial pouches. Int J Pediatr Otorhinolaryngol (2004) 1.53
Therapeutic induction of regulatory, cytotoxic CD8+ T cells in multiple sclerosis. J Immunol (2006) 1.48
Overexpression of CD7 in classical Hodgkin lymphoma-infiltrating T lymphocytes. Cytometry B Clin Cytom (2009) 1.43
Mycosis fungoides with tinea pseudoimbricata owing to Trichophyton rubrum infection. J Cutan Med Surg (2007) 1.39
Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy. Cancer (2012) 1.31
Activating FLT3 mutations are detectable in chronic and blast phase of chronic myeloproliferative disorders other than chronic myeloid leukemia. Am J Clin Pathol (2006) 1.28
The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance. Eur J Immunol (2002) 1.24
Differential dysfunction in dendritic cell subsets during chronic HCV infection. Clin Immunol (2007) 1.17
Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4(+) T-cell proliferation and IFN-γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein. Eur J Immunol (2010) 1.13
Immune regulatory CNS-reactive CD8+T cells in experimental autoimmune encephalomyelitis. J Autoimmun (2010) 1.11
The mechanism of action of glatiramer acetate treatment in multiple sclerosis. Neurology (2010) 1.10
IDH mutations in acute myeloid leukemia. Hum Pathol (2012) 1.06
Human regulatory T cells: a unique, stable thymic subset or a reversible peripheral state of differentiation? Immunol Lett (2007) 1.05
Hereditary lung cancer syndrome targets never smokers with germline EGFR gene T790M mutations. J Thorac Oncol (2014) 1.04
CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma: a clinicopathologic study of 14 cases. Hum Pathol (2012) 1.03
t(8;22)/BCR-FGFR1 myeloproliferative disorder presenting as B-acute lymphoblastic leukemia: report of a case treated with sorafenib and review of the literature. Leuk Res (2011) 1.02
The disease-ameliorating function of autoregulatory CD8 T cells is mediated by targeting of encephalitogenic CD4 T cells in experimental autoimmune encephalomyelitis. J Immunol (2013) 1.02
Characterization of immunophenotypic aberrancies in 200 cases of B acute lymphoblastic leukemia. Am J Clin Pathol (2009) 1.01
The emerging role of d-2-hydroxyglutarate as an oncometabolite in hematolymphoid and central nervous system neoplasms. Front Oncol (2013) 0.98
CTLA-4 regulates expansion and differentiation of Th1 cells following induction of peripheral T cell tolerance. J Immunol (2004) 0.97
Neuroantigen-specific CD8+ regulatory T-cell function is deficient during acute exacerbation of multiple sclerosis. J Autoimmun (2011) 0.96
Immunophenotypic study of basophils by multiparameter flow cytometry. Arch Pathol Lab Med (2008) 0.96
Novel JAK2 rearrangement resulting from a t(9;22)(p24;q11.2) in B-acute lymphoblastic leukemia. Leuk Res (2010) 0.94
Plasmablastic lymphomas with MYC/IgH rearrangement: report of three cases and review of the literature. Am J Clin Pathol (2009) 0.94
Hematogone hyperplasia in copper deficiency. Am J Clin Pathol (2009) 0.93
Flow cytometric analysis of monocytes as a tool for distinguishing chronic myelomonocytic leukemia from reactive monocytosis. Am J Clin Pathol (2005) 0.91
Immune regulation of multiple sclerosis by CD8+ T cells. Immunol Res (2014) 0.90
Prenatal stress causes gender-dependent neuronal loss and oxidative stress in rat hippocampus. J Neurosci Res (2004) 0.90
Multiparameter flow cytometric analysis reveals low percentage of bone marrow hematogones in myelodysplastic syndromes. Am J Clin Pathol (2008) 0.89
Echinacoside promotes bone regeneration by increasing OPG/RANKL ratio in MC3T3-E1 cells. Fitoterapia (2012) 0.88
Fever-range whole-body thermal therapy combined with cisplatin, gemcitabine, and daily interferon-alpha: a description of a phase I-II protocol. Int J Hyperthermia (2008) 0.88
Acute myeloid leukemia with inv(16) with CBFB-MYH11, 3'CBFB deletion, variant t(9;22) with BCR-ABL1, and del(7)(q22q32) in a pediatric patient: case report and literature review. Cancer Genet Cytogenet (2010) 0.87
Attack on the clones? Human FOXP3 detection by PCH101, 236A/E7, 206D, and 259D reveals 259D as the outlier with lower sensitivity. Blood (2008) 0.87
Notch1 in primary effusion lymphoma: a clinicopathological study. Mod Pathol (2010) 0.87
Unusual presentation of myeloid sarcoma in a case of acute promyelocytic leukemia with a cryptic PML-RARA rearrangement involving multiple sites including the atrium. Cancer Genet Cytogenet (2010) 0.86
Glatiramer acetate (GA) therapy induces a focused, oligoclonal CD8+ T-cell repertoire in multiple sclerosis. J Neuroimmunol (2006) 0.85
Clinical responders to antiviral therapy of chronic HCV infection show elevated antiviral CD4+ and CD8+ T-cell responses. J Viral Hepat (2007) 0.84
Tumor necrosis factor receptor 1 expression is upregulated in dendritic cells in patients with chronic HCV who respond to therapy. Hepat Res Treat (2010) 0.84
Flow cytometric features of angioimmunoblastic T-cell lymphoma. Cytometry B Clin Cytom (2006) 0.83
Simple karyotype and bcl-6 expression predict a diagnosis of Burkitt lymphoma and better survival in IG-MYC rearranged high-grade B-cell lymphomas. Mod Pathol (2010) 0.83
Genomic profiling using array comparative genomic hybridization define distinct subtypes of diffuse large B-cell lymphoma: a review of the literature. J Hematol Oncol (2012) 0.83
Clonal composition of neuroantigen-specific CD8+ and CD4+ T-cells in multiple sclerosis. J Neuroimmunol (2011) 0.82
CD8(+) T Cells Are Required For Glatiramer Acetate Therapy in Autoimmune Demyelinating Disease. PLoS One (2013) 0.82
Carotid cavernous fistula in CNS choriocarcinoma. Pediatr Blood Cancer (2008) 0.81
CD28-CD57+ T cells predominate in CD8 responses to glatiramer acetate. J Neuroimmunol (2006) 0.81
Significant CD5 expression on normal stage 3 hematogones and mature B Lymphocytes in bone marrow. Am J Clin Pathol (2009) 0.81
Acquired Glanzmann's thrombasthenia as part of multiple-autoantibody syndrome in a pediatric heart transplant patient. J Pediatr (2004) 0.81
Immunophenotypic studies of monoclonal gammopathy of undetermined significance. BMC Clin Pathol (2008) 0.81
Phenotypic characterization of autoreactive T cells in multiple sclerosis. J Neuroimmunol (2006) 0.81
Hereditary haemorrhagic telangiectasia involving the bone marrow and liver. Br J Haematol (2008) 0.80
IL-21 promotes the production of anti-DNA IgG but is dispensable for kidney damage in lyn-/- mice. Eur J Immunol (2012) 0.80
Modulation of immune function occurs within hours of therapy initiation for multiple sclerosis. Clin Immunol (2013) 0.80
Segmental tandem triplication of the MLL gene in an intravascular large B-cell lymphoma with multisystem involvement: a comprehensive morphologic, immunophenotypic, cytogenetic, and molecular cytogenetic antemortem study. Arch Pathol Lab Med (2009) 0.79
Chondroblastoma of the temporomandibular joint: report of a case and literature review. J Oral Maxillofac Surg (2009) 0.79
Stability of leukemia-associated immunophenotypes in precursor B-lymphoblastic leukemia/lymphoma: a single institution experience. Am J Clin Pathol (2007) 0.79
Viral interactions with B-cells contribute to increased regulatory T-cells during chronic HCV infection. Viral Immunol (2011) 0.79
High frequency of NPM1 gene mutations in acute myeloid leukemia with prominent nuclear invaginations ("cuplike" nuclei). Blood (2006) 0.78
The first case of Philadelphia chromosome-negative acute promyelocytic leukemia following imatinib for chronic myelogenous leukemia. Cancer Genet (2012) 0.78
Cytosolic phospholipase A(2)α protects against Fas- but not LPS-induced liver injury. J Hepatol (2011) 0.78
High incidence of IDH mutations in acute myeloid leukaemia with cuplike nuclei. Br J Haematol (2011) 0.78
In vitro methotrexate as a practical approach to selective allodepletion. Biol Blood Marrow Transplant (2007) 0.78
Mantle Cell Lymphoma With MYC Rearrangement: A Report of 17 Patients. Am J Surg Pathol (2016) 0.77
Differential usefulness of various markers in the flow cytometric detection of paroxysmal nocturnal hemoglobinuria in blood and bone marrow. Am J Clin Pathol (2006) 0.77
Bright CD38 expression is an indicator of MYC rearrangement. Leuk Lymphoma (2009) 0.77
Inverted and deleted chromosome 16 with deletion of 3'CBFB identified by fluorescence in situ hybridization. Cancer Genet Cytogenet (2007) 0.77
Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases. Am J Surg Pathol (2016) 0.76
Glatiramer acetate therapy: the plot thickens. Arch Neurol (2005) 0.75
Lineage determination in mixed phenotype acute leukemia: response to Marcondes et al. Cytometry B Clin Cytom (2014) 0.75
Uniform expression of Notch1, suppressor of B-cell-specific gene expression, in plasmablastic lymphoma. Arch Pathol Lab Med (2011) 0.75
Haematogones in the peripheral blood of adults: a four-colour flow cytometry study of 102 patients. Br J Haematol (2004) 0.75
Coexistence of t(12;21)(p13;q22)/ETV6-RUNX1 and 11q23/MLL Rearrangement in B Acute Lymphoblastic Leukemia: A Case Report and Review of the Literature. J Assoc Genet Technol (2011) 0.75
Infantile mixed phenotype acute leukemia (bilineal and biphenotypic) with t(10;11)(p12;q23);MLL-MLLT10. Leuk Res (2010) 0.75
Myelodysplastic syndrome (MDS)-associated cytogenetic abnormalities in pediatric chronic myelogenous leukemia. Pediatr Blood Cancer (2013) 0.75
Distinguishing Between Hepatosplenic T-cell Lymphoma and γδ T-cell Large Granular Lymphocytic Leukemia: A Clinicopathologic, Immunophenotypic, and Molecular Analysis. Am J Surg Pathol (2016) 0.75
Acute myeloid leukemia (M2) with a cryptic RUNX1/RUNX1T1 t(1;21;8)(p36;q22;q22) variant. Cancer Genet Cytogenet (2009) 0.75
Unusual expression of CD94 on CD8+ TCR-alpha beta T cells in infectious mononucleosis. Ann Diagn Pathol (2007) 0.75